Impact of prior use of topical hemostatic agents on trial of labor after cesarean: Insights from a multicenter cohort study.
Romi LevyHen Y SelaAri WeissReut RotemSorina Grisaru-GranovskyMisgav RottenstreichPublished in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2023)
A history of hemostatic agent use is not associated with an increased risk for uterine scar disruption after subsequent TOLAC. Further prospective studies in other settings are needed to strengthen these findings.